The Ensign Group, Inc. (NASDAQ: ENSG) Stock Competitors & Peer Comparison
See ENSG's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ENSG and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ENSG | $170.79 | -0.76% | 10B | 24.75 | $6.90 | +0.15% |
| HCA | $405.00 | -1.03% | 87.7B | 13.99 | $28.96 | +0.74% |
| THC | $265.05 | +0.59% | 21.3B | 15.37 | $17.24 | N/A |
| FMS | $22.66 | +0.85% | 12.2B | 8.52 | $2.66 | +3.81% |
| EHC | $121.79 | -0.65% | 12.1B | 20.85 | $5.84 | +0.62% |
| DVA | $183.99 | +1.28% | 11.8B | 14.37 | $12.80 | N/A |
| UHS | $169.65 | +0.26% | 10.3B | 7.53 | $22.54 | +0.47% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| CHE | $519.84 | -0.88% | 6.8B | 24.08 | $21.61 | +0.48% |
| PACS | $42.50 | -1.31% | 6.7B | 22.49 | $1.89 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
ENSG vs HCA Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, HCA has a market cap of 87.7B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while HCA trades at $405.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas HCA's P/E ratio is 13.99. In terms of profitability, ENSG's ROE is +0.17%, compared to HCA's ROE of -1.13%. Regarding short-term risk, ENSG is less volatile compared to HCA. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
ENSG vs THC Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, THC has a market cap of 21.3B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while THC trades at $265.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas THC's P/E ratio is 15.37. In terms of profitability, ENSG's ROE is +0.17%, compared to THC's ROE of +0.51%. Regarding short-term risk, ENSG is less volatile compared to THC. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check THC's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
ENSG vs FMS Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, FMS has a market cap of 12.2B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while FMS trades at $22.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas FMS's P/E ratio is 8.52. In terms of profitability, ENSG's ROE is +0.17%, compared to FMS's ROE of +0.07%. Regarding short-term risk, ENSG is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check FMS's competition here
Encompass Health Corporation (NYSE: EHC)
ENSG vs EHC Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, EHC has a market cap of 12.1B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while EHC trades at $121.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas EHC's P/E ratio is 20.85. In terms of profitability, ENSG's ROE is +0.17%, compared to EHC's ROE of +0.25%. Regarding short-term risk, ENSG is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check EHC's competition here
DaVita Inc. (NYSE: DVA)
ENSG vs DVA Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, DVA has a market cap of 11.8B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while DVA trades at $183.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas DVA's P/E ratio is 14.37. In terms of profitability, ENSG's ROE is +0.17%, compared to DVA's ROE of -1.24%. Regarding short-term risk, ENSG is less volatile compared to DVA. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check DVA's competition here
Universal Health Services, Inc. (NYSE: UHS)
ENSG vs UHS Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, UHS has a market cap of 10.3B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while UHS trades at $169.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas UHS's P/E ratio is 7.53. In terms of profitability, ENSG's ROE is +0.17%, compared to UHS's ROE of +0.21%. Regarding short-term risk, ENSG is less volatile compared to UHS. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check UHS's competition here
Oak Street Health, Inc. (NYSE: OSH)
ENSG vs OSH Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas OSH's P/E ratio is -17.65. In terms of profitability, ENSG's ROE is +0.17%, compared to OSH's ROE of +4.64%. Regarding short-term risk, ENSG is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check OSH's competition here
Chemed Corporation (NYSE: CHE)
ENSG vs CHE Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, CHE has a market cap of 6.8B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while CHE trades at $519.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas CHE's P/E ratio is 24.08. In terms of profitability, ENSG's ROE is +0.17%, compared to CHE's ROE of +0.29%. Regarding short-term risk, ENSG is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check CHE's competition here
PACS Group, Inc. (NYSE: PACS)
ENSG vs PACS Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, PACS has a market cap of 6.7B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while PACS trades at $42.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas PACS's P/E ratio is 22.49. In terms of profitability, ENSG's ROE is +0.17%, compared to PACS's ROE of +0.27%. Regarding short-term risk, ENSG is less volatile compared to PACS. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check PACS's competition here
Hims & Hers Health, Inc. (NYSE: HIMS)
ENSG vs HIMS Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, HIMS has a market cap of 6.2B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while HIMS trades at $27.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas HIMS's P/E ratio is -43.31. In terms of profitability, ENSG's ROE is +0.17%, compared to HIMS's ROE of -0.30%. Regarding short-term risk, ENSG is less volatile compared to HIMS. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check HIMS's competition here
LHC Group, Inc. (NASDAQ: LHCG)
ENSG vs LHCG Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas LHCG's P/E ratio is 82.83. In terms of profitability, ENSG's ROE is +0.17%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, ENSG is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
ENSG vs LFST Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, LFST has a market cap of 4.9B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while LFST trades at $12.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas LFST's P/E ratio is 95.88. In terms of profitability, ENSG's ROE is +0.17%, compared to LFST's ROE of +0.03%. Regarding short-term risk, ENSG is less volatile compared to LFST. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
ENSG vs CON Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, CON has a market cap of 4.4B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while CON trades at $34.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas CON's P/E ratio is 21.68. In terms of profitability, ENSG's ROE is +0.17%, compared to CON's ROE of +0.47%. Regarding short-term risk, ENSG is less volatile compared to CON. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check CON's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
ENSG vs OPCH Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, OPCH has a market cap of 3.6B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while OPCH trades at $24.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas OPCH's P/E ratio is 14.08. In terms of profitability, ENSG's ROE is +0.17%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, ENSG is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check OPCH's competition here
National HealthCare Corporation (AMEX: NHC)
ENSG vs NHC Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, NHC has a market cap of 3.4B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while NHC trades at $218.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas NHC's P/E ratio is 27.76. In terms of profitability, ENSG's ROE is +0.17%, compared to NHC's ROE of +0.13%. Regarding short-term risk, ENSG is less volatile compared to NHC. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check NHC's competition here
Amedisys, Inc. (NASDAQ: AMED)
ENSG vs AMED Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas AMED's P/E ratio is 39.30. In terms of profitability, ENSG's ROE is +0.17%, compared to AMED's ROE of +0.11%. Regarding short-term risk, ENSG is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check AMED's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
ENSG vs AVAH Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, AVAH has a market cap of 3B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while AVAH trades at $13.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas AVAH's P/E ratio is 19.97. In terms of profitability, ENSG's ROE is +0.17%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, ENSG is less volatile compared to AVAH. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check AVAH's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
ENSG vs BKD Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, BKD has a market cap of 2.8B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while BKD trades at $11.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas BKD's P/E ratio is -20.30. In terms of profitability, ENSG's ROE is +0.17%, compared to BKD's ROE of +4.06%. Regarding short-term risk, ENSG is less volatile compared to BKD. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check BKD's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
ENSG vs ACHC Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, ACHC has a market cap of 2.6B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while ACHC trades at $28.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas ACHC's P/E ratio is 14.14. In terms of profitability, ENSG's ROE is +0.17%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, ENSG is less volatile compared to ACHC. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check ACHC's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
ENSG vs GRDN Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, GRDN has a market cap of 2.6B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while GRDN trades at $40.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas GRDN's P/E ratio is 35.79. In terms of profitability, ENSG's ROE is +0.17%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, ENSG is less volatile compared to GRDN. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check GRDN's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
ENSG vs MD Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while MD trades at $27.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas MD's P/E ratio is 12.07. In terms of profitability, ENSG's ROE is +0.17%, compared to MD's ROE of +0.20%. Regarding short-term risk, ENSG is less volatile compared to MD. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check MD's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
ENSG vs ADUS Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while ADUS trades at $118.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas ADUS's P/E ratio is 17.78. In terms of profitability, ENSG's ROE is +0.17%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, ENSG is less volatile compared to ADUS. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check ADUS's competition here
Select Medical Holdings Corporation (NYSE: SEM)
ENSG vs SEM Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, SEM has a market cap of 2B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas SEM's P/E ratio is 15.43. In terms of profitability, ENSG's ROE is +0.17%, compared to SEM's ROE of +0.08%. Regarding short-term risk, ENSG is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check SEM's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
ENSG vs ASTH Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, ASTH has a market cap of 1.9B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while ASTH trades at $38.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas ASTH's P/E ratio is 46.35. In terms of profitability, ENSG's ROE is +0.17%, compared to ASTH's ROE of +0.05%. Regarding short-term risk, ENSG is less volatile compared to ASTH. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check ASTH's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
ENSG vs SGRY Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, SGRY has a market cap of 1.9B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while SGRY trades at $14.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas SGRY's P/E ratio is 36.56. In terms of profitability, ENSG's ROE is +0.17%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, ENSG is less volatile compared to SGRY. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check SGRY's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
ENSG vs AMEH Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas AMEH's P/E ratio is 39.25. In terms of profitability, ENSG's ROE is +0.17%, compared to AMEH's ROE of +0.05%. Regarding short-term risk, ENSG is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check AMEH's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
ENSG vs SNDA Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, SNDA has a market cap of 1.8B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while SNDA trades at $37.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas SNDA's P/E ratio is -6.09. In terms of profitability, ENSG's ROE is +0.17%, compared to SNDA's ROE of -0.26%. Regarding short-term risk, ENSG is less volatile compared to SNDA. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check SNDA's competition here
Ardent Health Inc. (NYSE: ARDT)
ENSG vs ARDT Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, ARDT has a market cap of 1.6B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while ARDT trades at $10.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas ARDT's P/E ratio is 8.79. In terms of profitability, ENSG's ROE is +0.17%, compared to ARDT's ROE of +0.05%. Regarding short-term risk, ENSG is less volatile compared to ARDT. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check ARDT's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
ENSG vs HCSG Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, HCSG has a market cap of 1.5B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while HCSG trades at $21.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas HCSG's P/E ratio is 17.46. In terms of profitability, ENSG's ROE is +0.17%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, ENSG is less volatile compared to HCSG. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check HCSG's competition here
Agilon Health, Inc. (NYSE: AGL)
ENSG vs AGL Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, AGL has a market cap of 1.5B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while AGL trades at $88.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas AGL's P/E ratio is -5.72. In terms of profitability, ENSG's ROE is +0.17%, compared to AGL's ROE of -1.19%. Regarding short-term risk, ENSG is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check AGL's competition here
Innovage Holding Corp. (NASDAQ: INNV)
ENSG vs INNV Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, INNV has a market cap of 1.5B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while INNV trades at $10.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas INNV's P/E ratio is -119.44. In terms of profitability, ENSG's ROE is +0.17%, compared to INNV's ROE of -0.09%. Regarding short-term risk, ENSG is less volatile compared to INNV. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check INNV's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
ENSG vs NUTX Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, NUTX has a market cap of 1.3B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while NUTX trades at $193.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas NUTX's P/E ratio is 7.65. In terms of profitability, ENSG's ROE is +0.17%, compared to NUTX's ROE of +0.52%. Regarding short-term risk, ENSG is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check NUTX's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
ENSG vs PNTG Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, PNTG has a market cap of 1.3B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while PNTG trades at $38.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas PNTG's P/E ratio is 28.79. In terms of profitability, ENSG's ROE is +0.17%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, ENSG is less volatile compared to PNTG. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check PNTG's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
ENSG vs AMN Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while AMN trades at $33.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas AMN's P/E ratio is 11.23. In terms of profitability, ENSG's ROE is +0.17%, compared to AMN's ROE of +0.15%. Regarding short-term risk, ENSG is less volatile compared to AMN. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check AMN's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
ENSG vs BKDT Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas BKDT's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to BKDT's ROE of +4.06%. Regarding short-term risk, ENSG is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check BKDT's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
ENSG vs USPH Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while USPH trades at $79.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas USPH's P/E ratio is 31.25. In terms of profitability, ENSG's ROE is +0.17%, compared to USPH's ROE of -0.01%. Regarding short-term risk, ENSG is less volatile compared to USPH. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check USPH's competition here
Talkspace, Inc. (NASDAQ: TALK)
ENSG vs TALK Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, TALK has a market cap of 879.4M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas TALK's P/E ratio is 774.34. In terms of profitability, ENSG's ROE is +0.17%, compared to TALK's ROE of +0.00%. Regarding short-term risk, ENSG is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check TALK's competition here
GMR Solutions Inc. (NYSE: GMRS)
ENSG vs GMRS Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, GMRS has a market cap of 728.1M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while GMRS trades at $13.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas GMRS's P/E ratio is 5.99. In terms of profitability, ENSG's ROE is +0.17%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, ENSG is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check GMRS's competition here
Enhabit, Inc. (NYSE: EHAB)
ENSG vs EHAB Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas EHAB's P/E ratio is -197.14. In terms of profitability, ENSG's ROE is +0.17%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, ENSG is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check EHAB's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
ENSG vs STLN Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, STLN has a market cap of 592.9M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while STLN trades at $5.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas STLN's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to STLN's ROE of +2.10%. Regarding short-term risk, ENSG is less volatile compared to STLN. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check STLN's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
ENSG vs TOI Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas TOI's P/E ratio is -14.25. In terms of profitability, ENSG's ROE is +0.17%, compared to TOI's ROE of +2.10%. Regarding short-term risk, ENSG is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check TOI's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
ENSG vs SRTA Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, SRTA has a market cap of 460.3M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while SRTA trades at $5.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas SRTA's P/E ratio is -25.08. In terms of profitability, ENSG's ROE is +0.17%, compared to SRTA's ROE of +0.14%. Regarding short-term risk, ENSG is less volatile compared to SRTA. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check SRTA's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
ENSG vs MCTA Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas MCTA's P/E ratio is 419.36. In terms of profitability, ENSG's ROE is +0.17%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, ENSG is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check MCTA's competition here
Community Health Systems, Inc. (NYSE: CYH)
ENSG vs CYH Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, CYH has a market cap of 406.8M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while CYH trades at $2.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas CYH's P/E ratio is 3.95. In terms of profitability, ENSG's ROE is +0.17%, compared to CYH's ROE of +0.21%. Regarding short-term risk, ENSG is less volatile compared to CYH. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check CYH's competition here
Auna S.A. (NYSE: AUNA)
ENSG vs AUNA Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, AUNA has a market cap of 391.6M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while AUNA trades at $5.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas AUNA's P/E ratio is 4.77. In terms of profitability, ENSG's ROE is +0.17%, compared to AUNA's ROE of +0.01%. Regarding short-term risk, ENSG is less volatile compared to AUNA. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check AUNA's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
ENSG vs VMD Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, VMD has a market cap of 345.8M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while VMD trades at $9.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas VMD's P/E ratio is 25.22. In terms of profitability, ENSG's ROE is +0.17%, compared to VMD's ROE of +0.10%. Regarding short-term risk, ENSG is less volatile compared to VMD. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check VMD's competition here
Capital Senior Living Corporation (NYSE: CSU)
ENSG vs CSU Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas CSU's P/E ratio is 0.67. In terms of profitability, ENSG's ROE is +0.17%, compared to CSU's ROE of -0.33%. Regarding short-term risk, ENSG is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check CSU's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
ENSG vs AIRS Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, AIRS has a market cap of 197.2M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while AIRS trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas AIRS's P/E ratio is -93.17. In terms of profitability, ENSG's ROE is +0.17%, compared to AIRS's ROE of -0.13%. Regarding short-term risk, ENSG is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check AIRS's competition here
The Joint Corp. (NASDAQ: JYNT)
ENSG vs JYNT Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, JYNT has a market cap of 118.6M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while JYNT trades at $8.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas JYNT's P/E ratio is 83.20. In terms of profitability, ENSG's ROE is +0.17%, compared to JYNT's ROE of +0.22%. Regarding short-term risk, ENSG is less volatile compared to JYNT. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check JYNT's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
ENSG vs FVE Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas FVE's P/E ratio is -5.64. In terms of profitability, ENSG's ROE is +0.17%, compared to FVE's ROE of -0.15%. Regarding short-term risk, ENSG is less volatile compared to FVE. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
ENSG vs KDLYW Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas KDLYW's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, ENSG is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check KDLYW's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
ENSG vs PARK Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, PARK has a market cap of 92.2M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while PARK trades at $20.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas PARK's P/E ratio is 27.61. In terms of profitability, ENSG's ROE is +0.17%, compared to PARK's ROE of -0.18%. Regarding short-term risk, ENSG is less volatile compared to PARK. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check PARK's competition here
biote Corp. (NASDAQ: BTMD)
ENSG vs BTMD Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, BTMD has a market cap of 68.1M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while BTMD trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas BTMD's P/E ratio is 14.05. In terms of profitability, ENSG's ROE is +0.17%, compared to BTMD's ROE of -0.09%. Regarding short-term risk, ENSG is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check BTMD's competition here
AlerisLife Inc. (NASDAQ: ALR)
ENSG vs ALR Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas ALR's P/E ratio is -1.11. In terms of profitability, ENSG's ROE is +0.17%, compared to ALR's ROE of -0.15%. Regarding short-term risk, ENSG is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check ALR's competition here
DocGo Inc. (NASDAQ: DCGO)
ENSG vs DCGO Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, DCGO has a market cap of 39.8M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while DCGO trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas DCGO's P/E ratio is -0.22. In terms of profitability, ENSG's ROE is +0.17%, compared to DCGO's ROE of -1.16%. Regarding short-term risk, ENSG is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check DCGO's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
ENSG vs CCEL Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, CCEL has a market cap of 34.5M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while CCEL trades at $4.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas CCEL's P/E ratio is -14.27. In terms of profitability, ENSG's ROE is +0.17%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, ENSG is less volatile compared to CCEL. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check CCEL's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
ENSG vs IMAC Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas IMAC's P/E ratio is -2.27. In terms of profitability, ENSG's ROE is +0.17%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, ENSG is less volatile compared to IMAC. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check IMAC's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
ENSG vs PIII Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, PIII has a market cap of 30.6M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while PIII trades at $9.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas PIII's P/E ratio is -0.28. In terms of profitability, ENSG's ROE is +0.17%, compared to PIII's ROE of +1.61%. Regarding short-term risk, ENSG is less volatile compared to PIII. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check PIII's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
ENSG vs EUDA Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, EUDA has a market cap of 25.4M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while EUDA trades at $13.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas EUDA's P/E ratio is -25.66. In terms of profitability, ENSG's ROE is +0.17%, compared to EUDA's ROE of +1.20%. Regarding short-term risk, ENSG is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check EUDA's competition here
P3 Health Partners Inc. (NASDAQ: PIIIW)
ENSG vs PIIIW Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, PIIIW has a market cap of 24.5M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas PIIIW's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to PIIIW's ROE of +1.61%. Regarding short-term risk, ENSG is less volatile compared to PIIIW. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check PIIIW's competition here
Cano Health, Inc. (NYSE: CANO-WT)
ENSG vs CANO-WT Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, ENSG is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
ENSG vs AIH Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas AIH's P/E ratio is -2.78. In terms of profitability, ENSG's ROE is +0.17%, compared to AIH's ROE of +1.16%. Regarding short-term risk, ENSG is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check AIH's competition here
Cano Health, Inc. (NYSE: CANO)
ENSG vs CANO Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas CANO's P/E ratio is -0.01. In terms of profitability, ENSG's ROE is +0.17%, compared to CANO's ROE of -1.49%. Regarding short-term risk, ENSG is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
ENSG vs FPCG Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas FPCG's P/E ratio is 0.09. In terms of profitability, ENSG's ROE is +0.17%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, ENSG is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check FPCG's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
ENSG vs FTRP Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas FTRP's P/E ratio is -1.22. In terms of profitability, ENSG's ROE is +0.17%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, ENSG is less volatile compared to FTRP. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check FTRP's competition here
American Shared Hospital Services (AMEX: AMS)
ENSG vs AMS Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, AMS has a market cap of 9.5M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while AMS trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas AMS's P/E ratio is -5.66. In terms of profitability, ENSG's ROE is +0.17%, compared to AMS's ROE of -0.07%. Regarding short-term risk, ENSG is less volatile compared to AMS. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check AMS's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
ENSG vs BMGL Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, BMGL has a market cap of 7.6M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while BMGL trades at $4.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas BMGL's P/E ratio is -0.91. In terms of profitability, ENSG's ROE is +0.17%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, ENSG is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check BMGL's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
ENSG vs AIDX Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, AIDX has a market cap of 7.2M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while AIDX trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas AIDX's P/E ratio is -1.12. In terms of profitability, ENSG's ROE is +0.17%, compared to AIDX's ROE of -3.87%. Regarding short-term risk, ENSG is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check AIDX's competition here
ModivCare Inc. (NASDAQ: MODV)
ENSG vs MODV Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas MODV's P/E ratio is -0.06. In terms of profitability, ENSG's ROE is +0.17%, compared to MODV's ROE of +1.36%. Regarding short-term risk, ENSG is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check MODV's competition here
Starling Oncology Inc. Wt (NASDAQ: STLNW)
ENSG vs STLNW Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, STLNW has a market cap of 5.5M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while STLNW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas STLNW's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to STLNW's ROE of +2.10%. Regarding short-term risk, ENSG is more volatile compared to STLNW. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check STLNW's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
ENSG vs GBNH Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas GBNH's P/E ratio is -0.06. In terms of profitability, ENSG's ROE is +0.17%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, ENSG is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE)
ENSG vs RHE Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas RHE's P/E ratio is -1.79. In terms of profitability, ENSG's ROE is +0.17%, compared to RHE's ROE of -1.31%. Regarding short-term risk, ENSG is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check RHE's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
ENSG vs RHE-PA Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, ENSG's ROE is +0.17%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, ENSG is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check RHE-PA's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
ENSG vs TOIIW Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, ENSG's ROE is +0.17%, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, ENSG is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check TOIIW's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
ENSG vs IMACW Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas IMACW's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, ENSG is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check IMACW's competition here
Endovia Health Sciences, Inc. (AMEX: EDVA)
ENSG vs EDVA Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, EDVA has a market cap of 1.7M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while EDVA trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas EDVA's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to EDVA's ROE of N/A. Regarding short-term risk, ENSG is less volatile compared to EDVA. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check EDVA's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
ENSG vs EUDAW Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, EUDAW has a market cap of 1.1M. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while EUDAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas EUDAW's P/E ratio is 0.04. In terms of profitability, ENSG's ROE is +0.17%, compared to EUDAW's ROE of +1.20%. Regarding short-term risk, ENSG is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check EUDAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
ENSG vs CCM Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, CCM has a market cap of 642.2K. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while CCM trades at $4.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas CCM's P/E ratio is -0.30. In terms of profitability, ENSG's ROE is +0.17%, compared to CCM's ROE of +0.06%. Regarding short-term risk, ENSG is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
ENSG vs NIVF Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, NIVF has a market cap of 72K. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while NIVF trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas NIVF's P/E ratio is 0.56. In terms of profitability, ENSG's ROE is +0.17%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, ENSG is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check NIVF's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
ENSG vs NIVFW Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, NIVFW has a market cap of 45.5K. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, ENSG's ROE is +0.17%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, ENSG is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check NIVFW's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
ENSG vs MNDR Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, MNDR has a market cap of 34.9K. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while MNDR trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas MNDR's P/E ratio is -0.04. In terms of profitability, ENSG's ROE is +0.17%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, ENSG is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check MNDR's competition here
Talkspace, Inc. (NASDAQ: TALKW)
ENSG vs TALKW Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas TALKW's P/E ratio is 0.00. In terms of profitability, ENSG's ROE is +0.17%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, ENSG is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check TALKW's competition here
DocGo Inc. (NASDAQ: DCGOW)
ENSG vs DCGOW Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas DCGOW's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to DCGOW's ROE of -1.16%. Regarding short-term risk, ENSG is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check DCGOW's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
ENSG vs TVTY Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, TVTY has a market cap of 0. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas TVTY's P/E ratio is 19.06. In terms of profitability, ENSG's ROE is +0.17%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, ENSG is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check TVTY's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
ENSG vs ATIP-WT Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, ENSG is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check ATIP-WT's competition here
New Frontier Health Corporation (NYSE: NFH)
ENSG vs NFH Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, NFH has a market cap of 0. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas NFH's P/E ratio is -19.75. In terms of profitability, ENSG's ROE is +0.17%, compared to NFH's ROE of -0.06%. Regarding short-term risk, ENSG is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check NFH's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
ENSG vs DVCR Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, DVCR has a market cap of 0. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas DVCR's P/E ratio is 28.34. In terms of profitability, ENSG's ROE is +0.17%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, ENSG is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check DVCR's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
ENSG vs TLMDW Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas TLMDW's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, ENSG is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check TLMDW's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
ENSG vs SLHGP Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, ENSG's ROE is +0.17%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, ENSG is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check SLHGP's competition here
Hanger, Inc. (NYSE: HNGR)
ENSG vs HNGR Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, HNGR has a market cap of 0. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas HNGR's P/E ratio is 19.71. In terms of profitability, ENSG's ROE is +0.17%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, ENSG is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check HNGR's competition here
Almost Family Inc. (NASDAQ: AFAM)
ENSG vs AFAM Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, AFAM has a market cap of 0. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas AFAM's P/E ratio is N/A. In terms of profitability, ENSG's ROE is +0.17%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, ENSG is less volatile compared to AFAM. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
ENSG vs TLMD Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, TLMD has a market cap of 0. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas TLMD's P/E ratio is -1.60. In terms of profitability, ENSG's ROE is +0.17%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, ENSG is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check TLMD's competition here
Kindred Healthcare, Inc. (NYSE: KND)
ENSG vs KND Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, KND has a market cap of 0. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas KND's P/E ratio is -1.14. In terms of profitability, ENSG's ROE is +0.17%, compared to KND's ROE of -0.53%. Regarding short-term risk, ENSG is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for ENSG.Check KND's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
ENSG vs SLHG Comparison September 2026
The Ensign Group, Inc. (NASDAQ: ENSG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ENSG stands at 10B. In comparison, SLHG has a market cap of 0. Regarding current trading prices, ENSG is priced at $170.79 on the NASDAQ, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ENSG currently has a P/E ratio of 24.75, whereas SLHG's P/E ratio is -1.48. In terms of profitability, ENSG's ROE is +0.17%, compared to SLHG's ROE of N/A. Regarding short-term risk, ENSG is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for ENSG.Check SLHG's competition here